pillbase.ru

Kyinsu

Active substance: insulin icodec, semaglutide

insulin icodec, semaglutide

Centralised EU authorisationActive

Marketing holder: Novo Nordisk A/S

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Products containing insulin icodec in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

CountryProducts
US 2
  • Awiqli
    INJECTION, SOLUTION · INSULIN ICODEC 700 U/mL
    0169-3105
    Novo Nordisk Pharmaceutical Industries, LP
  • Awiqli
    INJECTION, SOLUTION · INSULIN ICODEC 700 U/mL
    0169-3170
    Novo Nordisk Pharmaceutical Industries, LP
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a12095-c6bc-7c18-ad5a-ad8986d6fc15,01a12098-7042-7842-a495-941631ace610;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/006279
Registration status
Active
ATC code
A10AE57
Sources
  • product · EMA · EMEA/H/C/006279 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/006279 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/006279 · Verified 2026-10-09
  • ingredients.1 · EMA · EMEA/H/C/006279 · Verified 2026-10-09